1. Actual practice of melanoma follow‐up and treatment in Germany: results of a prospective, longitudinal cohort study. (29th April 2015) Authors: Livingstone, E.; Eigentler, T.K.; Windemuth‐Kieselbach, C.; Hauschild, A.; Rompel, R.; Trefzer, U.; Nashan, D.; Kilian, K.; Debus, D.; Kähler, K.C.; Mauerer, A.; Möllenhoff, K.; Dippel, E.; Schadendorf, D. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T‐cell lymphoma: reply from the authors. (1st January 2018) Authors: Stranzenbach, R.; Dippel, E.; Schlaak, M.; Stadler, R. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Actual practice of melanoma follow‐up and treatment in Germany: results of a prospective, longitudinal cohort study. (1st June 2015) Authors: Livingstone, E.; Eigentler, T.K.; Windemuth‐Kieselbach, C.; Hauschild, A.; Rompel, R.; Trefzer, U.; Nashan, D.; Kilian, K.; Debus, D.; Kähler, K.C.; Mauerer, A.; Möllenhoff, K.; Dippel, E.; Schadendorf, D. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature. (1st December 2017) Authors: Stranzenbach, R.; Dippel, E.; Schlaak, M.; Stadler, R. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T‐cell lymphoma: reply from the authors. (29th December 2017) Authors: Stranzenbach, R.; Dippel, E.; Schlaak, M.; Stadler, R. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature. (22nd November 2017) Authors: Stranzenbach, R.; Dippel, E.; Schlaak, M.; Stadler, R. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal study. Issue 5 (March 2015) Authors: Livingstone, E.; Krajewski, C.; Eigentler, T.K.; Windemuth-Kieselbach, C.; Benson, S.; Elsenbruch, S.; Hauschild, A.; Rompel, R.; Meiss, F.; Mauerer, A.; Kähler, K.C.; Dippel, E.; Möllenhoff, K.; Kilian, K.; Mohr, P.; Utikal, J.; Schadendorf, D. Journal: European journal of cancer Issue: Volume 51:Issue 5(2015:Mar.) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Actual practice of melanoma follow‐up and treatment in Germany: results of a prospective, longitudinal cohort study. (29th April 2015) Authors: Livingstone, E.; Eigentler, T.K.; Windemuth‐Kieselbach, C.; Hauschild, A.; Rompel, R.; Trefzer, U.; Nashan, D.; Kilian, K.; Debus, D.; Kähler, K.C.; Mauerer, A.; Möllenhoff, K.; Dippel, E.; Schadendorf, D. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗